Related Experiment Video

Updated: May 9, 2026

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

[Roles of targeting Ras/Raf/MEK/ERK signaling pathways in the treatment of esophageal carcinoma]

Yu-Sui Chang1, Ji-Chun Liu, Hua-Qun Fu

  • 1Department of Thoracic and Cardiovascular Surgery, First Affiliated Hospital, Nanchang University Nanchang 330006, China. cyscys2005@126.com

Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|July 30, 2013
PubMed

Insights

Mutations in Ras proteins drive abnormal cell proliferation, leading to cancer. Understanding the Ras/Raf/MEK/ERK pathway is crucial for developing targeted esophageal cancer therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Ras proteins regulate fundamental cellular processes including growth, proliferation, and differentiation.
  • Aberrant Ras signaling is implicated in the pathogenesis of numerous human cancers.
  • The Ras/Raf/MEK/ERK pathway is a critical signaling cascade involved in tumor development and progression.

Purpose of the Study:

  • To review the molecular mechanisms of the Ras/Raf/MEK/ERK signaling pathway in esophageal carcinoma.
  • To identify potential pharmacological targeting points within this pathway for cancer treatment.

Main Methods:

  • Literature review of studies on Ras signaling in cancer.
  • Analysis of molecular mechanisms underlying the Ras/Raf/MEK/ERK pathway.
  • Examination of existing and potential therapeutic strategies targeting this pathway.

Main Results:

  • The Ras/Raf/MEK/ERK pathway plays a significant role in the development and progression of esophageal carcinoma.
  • Specific components of the pathway are associated with tumor prognosis.
  • The pathway offers several potential targets for chemotherapeutic intervention.

Conclusions:

  • Elucidating the intricate roles of the Ras/Raf/MEK/ERK pathway in esophageal cancer is essential for advancing targeted treatment strategies.
  • Targeting this pathway holds promise for improving therapeutic outcomes in esophageal carcinoma.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...